Cognitive Behavioral Affective Therapy for Anger
Trial Summary
What is the purpose of this trial?
This trial aims to test the effectiveness of Cognitive Behavioral Affective Therapy (CBAT) in helping people who struggle with excessive anger. The therapy teaches techniques to manage anger by recognizing triggers and using calming strategies. The goal is to reduce the negative impact of anger on health and behavior.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, you cannot be undergoing any psychological or psychiatric treatment to participate.
What data supports the effectiveness of Cognitive Behavioral Affective Therapy for Anger?
Is Cognitive Behavioral Affective Therapy for Anger safe for humans?
Research on cognitive behavioral therapy (CBT) for anger, including studies on veterans and individuals with traumatic brain injury, suggests that it is generally safe for humans. These studies have not reported significant safety concerns, indicating that CBT-based treatments for anger are typically well-tolerated.14678
How is Cognitive Behavioral Affective Therapy (CBAT) for anger different from other treatments?
Cognitive Behavioral Affective Therapy (CBAT) for anger is unique because it combines traditional cognitive-behavioral techniques with a focus on emotional regulation and motivation, addressing both the cognitive and affective aspects of anger. This approach is more comprehensive than standard anger management therapies, which may not fully integrate these components.345910
Research Team
Eligibility Criteria
This trial is for individuals who struggle with excessive anger, such as those with Intermittent Explosive Disorder or related conditions. It's aimed at people whose anger leads to distress and problems in daily life. Participants should be interested in exploring therapy to manage their emotions.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Cognitive Behavioral Affective Therapy (CBAT) or Emotional Education (EE) through video sessions over 4 weeks
Interim Period
Participants have a 3-week interim period to reflect and implement learned techniques
Follow-up
Participants are monitored for safety and effectiveness after treatment, including a final follow-up session
Treatment Details
Interventions
- Cognitive Behavioral Affective Therapy (Behavioral Intervention)
Cognitive Behavioral Affective Therapy is already approved in Canada for the following indications:
- Intermittent Explosive Disorder
- Anxiety Disorders
- Chronic Pain Management
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas at San Antonio
Lead Sponsor